XML 15 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statement of Cash Flows (Unaudited) - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net (loss) earnings $ (20) $ 76
Adjustments to reconcile to net cash used in operating activities:    
Depreciation and amortization 21 21
Pension and postretirement income (42) (111)
Asset impairment [1] 21  
Paid-in-kind interest expense 36 17
Non-cash changes in workers' compensation and employee benefit reserves   1
Stock based compensation 4 5
Net gain from sale of assets   (17)
Provision for deferred income taxes 1  
Decrease in trade receivables   52
Decrease (increase) in miscellaneous receivables 2 (6)
Increase in inventories (12) (25)
Decrease in trade payables (15) (1)
Decrease in liabilities excluding borrowings and trade payables (22) (39)
Other items, net 17 16
Total adjustments 11 (87)
Net cash used in operating activities (9) (11)
Cash flows from investing activities:    
Additions to properties (28) (39)
Proceeds from sale of assets 5 17
Net cash used in investing activities (23) (22)
Cash flows from financing activities:    
Net proceeds from ATM equity offering program 1  
Preferred stock cash dividend payments (2) (3)
Treasury stock purchases (2) (1)
Net cash used in financing activities (3) (21)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 5 (1)
Net decrease in cash, cash equivalents and restricted cash (30) (55)
Cash, cash equivalents and restricted cash, beginning of period 301 377
Cash, cash equivalents and restricted cash, end of period 271 322
Non-cash financing activities:    
Series C preferred stock exchange to common stock $ 124  
Amended and Restated Term Loan Agreement [Member]    
Cash flows from financing activities:    
Repayment of debt   $ (17)
[1] During the second quarter of 2025, Kodak recorded an impairment charge of $17 million related to its investment in Wildcat Discovery Technologies, Inc. (“Wildcat”) due to the strategic options and alternatives being contemplated by Wildcat as a result of the current economic environment. The fair value of Kodak’s investment in Wildcat was estimated using a probability weighted assessment of the various options being considered under a combination of market and income approaches (Level 3). With respect to an observable transaction for a similar investment that occurred in October 2025, Kodak recorded an additional impairment charge of $4 million related to its investment in Wildcat during the third quarter of 2025. The fair value of Kodak's investment in Wildcat was estimated using a market approach (Level 3). The carrying value of Kodak’s investment in Wildcat as of September 30, 2025 approximated $4 million.